HEPZATO KIT™ & Opdualag™Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

Sponsor:

University of Wisconsin, Madison

Code:

NCT07281924

Conditions

Metastatic Melanoma

Liver Metastases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nivolumab and Relatlimab

Melphalan

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by University of Wisconsin, Madison on 2026-07-29.